Cell Therapy News Volume 25.19 | Jun 17 2024

    0
    62








    2024-06-17 | CTN 25.19


    Cell Therapy News by STEMCELL Technologies
    Vol. 25.19 – 17 June, 2024
    TOP STORY

    PSCA-CAR T Cell Therapy in Metastatic Castration-Resistant Prostate Cancer: A Phase I Trial

    Scientists reported results from a Phase II, first-in-human study of prostate stem cell antigen (PSCA)-directed CAR T cells in men with metastatic castration-resistant prostate cancer.
    [Nature Medicine]

    Full Article
    Be sure the cells you’re gene editing are still HSPCs with StemSpan™ SFEM II culture medium.
    PUBLICATIONSRanked by the impact factor of the journal

    Efficient Site-Specific Integration of Large Genes in Mammalian Cells via Continuously Evolved Recombinases and Prime Editing

    The authors showed that phage-assisted continuous evolution enhances prime-editing-assisted site-specific integrase gene editing, which coupled the programmability of prime editing with the ability of recombinases to precisely integrate large DNA cargoes exceeding 10 kilobases.
    [Nature Biomedical Engineering]

    Full Article

    In Vivo CAR T Cell Generation in Non-Human Primates Using Lentiviral Vectors Displaying a Multi-Domain Fusion Ligand

    Investigators have developed the VivoVecTM platform, a lentiviral vector capable of generating CAR T-cells in vivo.
    [Blood]

    Abstract

    Transient Growth Factor Expression via mRNA in Lipid Nanoparticles Promotes Hepatocyte Cell Therapy in Mice

    Scientists refined two male mouse models of human chronic and acute liver diseases to recapitulate compromised hepatocyte proliferation observed in nearly all human liver diseases by overexpression of p21 in hepatocytes.
    [Nature Communications]

    Full Article

    CRISPR-Mediated Sox9 Activation and RelA Inhibition Enhance Cell Therapy for Osteoarthritis

    Researchers used Sox9 activation and RelA inhibition, both mediated by the CRISPR/dCas9 technology simultaneously, to engineer MSCs with enhanced chondrogenic potential and downregulated inflammatory responses.
    [Molecular Therapy]

    AbstractGraphical Abstract

    Thymidylate Synthase Disruption to Limit Cell Proliferation in Cell Therapies

    The authors described a safety system to control cell proliferation while allowing robust and efficient cell manufacture, without any added genetic elements.
    [Molecular Therapy]

    Abstract

    Stromal Cells Engineered to Express T Cell Factors Induce Robust CLL Cell Proliferation In Vitro and in PDX Co-Transplantations Allowing the Identification of RAF Inhibitors As Anti-Proliferative Drugs

    The authors prepared a novel model based on mimicking T cell signals in vitro and in patient-derived xenografts. Six supportive cell lines were prepared by engineering HS5 stromal cells with stable expression of human CD40L, IL4, IL21, and their combinations.
    [Leukemia]

    Full ArticleGraphical Abstract

    Longitudinal Magnetic Resonance Imaging Tracking of Transplanted Neural Progenitor Cells in the Spinal Cord Utilizing the Bright-Ferritin Mechanism

    Investigators applied a novel bright-ferritin magnetic resonance imaging mechanism to track human neural progenitor cells (hNPC) transplants longitudinally and on demand in the rat spinal cord. They genetically modified hNPCs to stably overexpress human ferritin.
    [Stem Cells Translational Medicine]

    Full ArticleGraphical Abstract

    The Postnatal Injection of AAV9-FOXG1 Rescues Corpus Callosum Agenesis and Other Brain Deficits in the Mouse Model of FOXG1 Syndrome

    Scientists explored the therapeutic potential of adeno-associated virus 9 (AAV9) mediated delivery of the FOXG1 gene. Remarkably, intracerebroventricular injection of AAV9-FOXG1 to Foxg1 heterozygous mouse model at the postnatal stage rescued a wide range of brain pathologies.
    [Molecular Therapy-Methods & Clinical Development]

    AbstractFull ArticlePress Release
    Graphical Abstract

    Intravenous Application of Human Umbilical Cord Mesenchymal Stem Cells Alleviate Neuropathic Pain by Suppressing Microglia Activation in Rats

    Researchers verified the analgesic effect of intravenous administration of human umbilical cord mesenchymal stem cells upon rats with chronic constriction injury-induced neuropathic pain and the concomitant mechanism via modulating microglia.
    [Heliyon]

    Full Article
    Free wallchart: MSC-derived exosomes
    REVIEWS

    Immunotherapy for Hepatocellular Carcinoma: The Next Evolution in Expanding Access to Liver Transplantation

    Investigators discuss the mechanisms supporting combination immunotherapy, summarize key recent clinical data from major immunotherapy trials, and explore how immunotherapy can be applied in the neoadjuvant setting prior to liver transplantation in selected high-risk patients.
    [Journal of Hepatology]

    Press Release

    Virus Specific T Cell Therapy to Treat Refractory Viral infections in Solid Organ Transplant Recipients

    The authors provide a state-of-the-art update of the current virus specific T cell pipeline and translational research that is likely to lead to further treatment options for viral infections in solid organ transplant recipients.
    [American Journal of Transplantation]

    Abstract
    INDUSTRY AND POLICY NEWS

    Hope, Despair and CRISPR — the Race to Save One Woman’s Life

    Researchers in India fought to develop what could have been the first therapy to use gene-editing to halt a rare neurodegenerative disease. The efforts hold lessons for the messy state of modern drug development.
    [Nature News]

    Editorial

    Seraxis Wins Maryland Stem Cell Research Fund Grant to Accelerate Development of Allogenetically Compatible Pancreatic Islet Replacement Therapy for Functional Cure of T1D

    Seraxis, Inc. has been notified that the company is the awardee of a $400,000 Commercialization Program grant from the Maryland Stem Cell Research Fund that aims to foster Maryland research to enhance and propel stem cell treatments.
    [Seraxis (Newswire)]

    Press Release
    FEATURED EVENT

    Lipid Droplets: From Mechanisms to Disease

    July 21 – 25, 2024
    Saint Paul, Minnesota, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoc – Retinal Organoid Disease Modeling

    Penn Medicine – Philadelphia, Pennsylvania, United States

    Professor – Science Research

    KU Leuven – Leuven, Belgium

    Project Scientist – Liver Regeneration and Vesicle Researcher

    UC San Diego – San Diego, California, United States

    Project Scientist – Liver Regeneration and Vesicle Researcher

    UC San Diego – San Diego, California, United States

    Postdoctoral Fellow – Transplant Research Position

    University of Maryland, Baltimore – Baltimore, Maryland, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2